CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...

CEO Roderick de Greef highlighted strong quarterly performance, stating that "cell processing revenue increased 33% year-over-year, driving a 31% increase in total revenue for the quarter." He ...

BioLife Solutions reported third-quarter 2025 results, with revenue of US$28.07 million and net income of US$621,000, also updating its full-year guidance upward after completing the sale of its evo ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on BioLife Solutions (BLFS – Research Report) yesterday and set a price target of $30.00. Don't Miss our Black Friday Offers: Jason McCarthy ...

BOTHELL, Wash., Nov. 12, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell ...